The engraftment of GFP+EpCAM+ cancer cells from WD-SCCs into immunocompetent syngeneic mice gave rise to tumors with a reduced percentage of GFP+EpCAM− cancer cells (Fig. 1b). This evidence concerns the gene EPCAM and cancer.